Nursing Home Device Incidents: Prepare User-Facility Reports

Use the user-facility rule

The FDA mandatory-reporting overview includes nursing homes in the device-user-facility category. 21 CFR 803.30 requires suspected device-related deaths to be reported to FDA and to the manufacturer if known, as soon as practicable and no more than ten work days after the day of awareness. Serious injuries go to the manufacturer, or to FDA if the manufacturer is unknown, no later than ten work days after the awareness day.

Do not import the manufacturer's thirty-calendar-day schedule into the facility's process. Qualified reviewers determine whether an actual event meets the reporting criteria; the system should preserve the facts and timing needed for that decision rather than wait for definitive proof of causation.

Route three fictional events

These assumed classifications illustrate routing only. They do not determine causation or seriousness for a real event. Immediate resident care and safety actions proceed through qualified staff without waiting for reporting paperwork.

Complete the two-recipient case

Section 803.3 ties user-facility awareness to medical personnel employed by or formally affiliated with the facility. Its definition includes employees responsible for receiving medical complaints or adverse-event reports; it is not limited to a physician or compliance officer. Work days are Monday through Friday except federal holidays.

In the fictional death case, the incident enters a maintenance queue at 08:20, and the facility's designated adverse-event intake employee obtains potentially reportable information that morning. The compliance reviewer preserves the actual awareness chronology rather than starting a new clock when the case is reassigned two days later.

The facility identifies the device, retains relevant records through its authorized process and prepares the required report using current FDA instructions. The first transmission reaches the manufacturer. The case remains open because the FDA transmission has not yet been confirmed. After both are completed, the record links the report versions, destinations and delivery evidence.

A manufacturer response saying it will investigate does not replace the facility's required FDA report. Likewise, a later technical conclusion is preserved as follow-up rather than used to erase the original basis for reporting.

Maintain a reproducible review record

21 CFR 803.17 requires written procedures for timely identification, communication, evaluation and reporting, plus records of evaluated information, submitted reports and annual-report preparation. Keep the decision rationale and source evidence even when the review concludes the event is not reportable under this rule.

Protect resident information and device evidence through the appropriate clinical, privacy and technical processes. Do not perform an unapproved destructive test or dispose of equipment merely to close a work order. Qualified personnel determine safe handling and preservation.

Reconcile the annual summary

21 CFR 803.33 requires the annual user-facility report by January 1 and specifies its content. It also states that no annual report is needed when no medical-device reports were submitted to manufacturers or FDA during the period.

Reconcile the annual summary to the actual report register, including recipients and report identifiers. The absence of an incident in a general safety dashboard is not evidence that no report was submitted through another department.

For a platform buyer, the two-recipient case tests whether clinical events, device identity, compliance review and external report receipts remain connected. The finished result is an explainable reporting record, not merely a closed maintenance ticket.